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Background/aim: This study aimed to compare the effectiveness of ultrasound (US)-guided injection versus blind injection of
corticosteroids in the treatment of carpal tunnel syndrome (CTS).
Materials and methods: This prospective, randomized clinical trial included patients with severe CTS based on clinical and
electrophysiological criteria. The patients were evaluated for clinical and electrophysiological parameters at baseline and 4 weeks after
treatment. Symptom severity and hand function were assessed by the Boston questionnaire. The patients underwent blind injection or
US-guided injection.
Results: When compared with baseline, both groups showed significant improvement in Boston questionnaire scores and all
electrophysiological parameters. Significant differences were observed between the groups for clinical parameters (Boston Symptom
Severity Scale: P = 0.007; Functional Status Scale: P < 0.001) in favor of the US-guided group.
Conclusion: This study demonstrated that both US-guided and blind injections were effective in reducing symptoms and improving
hand function. US-guided injections may yield more effective clinical results in the short-term than blind injections in the treatment of
patients with severe CTS.
Key words: Carpal tunnel syndrome, ultrasound-guided, blind, injection, corticosteroid

1. Introduction
Carpal tunnel syndrome (CTS) is the most frequent
entrapment neuropathy in the upper limbs (1). The carpal
tunnel is bordered by the transverse carpal ligament
superiorly and carpal bones inferiorly. As the median
nerve crosses the wrist, it passes through the carpal
tunnel along with nine flexor muscle tendons. While the
precise etiology of increased carpal tunnel pressure in
CTS is uncertain, experimental evidence suggests that
anatomic compression and/or inflammation are possible
mechanisms (2,3).
Local steroid injection into the carpal tunnel is an
effective treatment option and is frequently used. According
to the Cochrane database, local steroid injection for CTS
provides greater clinical improvement in symptoms 1
month after injection compared with placebos (4,5). In our
previous study, we found that local steroid injection and
surgical decompression achieved favorable improvements
in clinical and electrophysiological parameters within
the short term without superiority of one treatment
* Correspondence: drozguroz@gmail.com

over other (6). Therefore, in patients for whom surgical
decompression cannot be applied, a local steroid injection
can be recommended as a less invasive and promising
treatment alternative.
Injections are commonly performed with a blind
technique using palpation of anatomical landmarks in
daily clinical practice (7,8). This technique does not
provide certainty on whether the injected steroid is
adequately placed in the carpal tunnel. A cadaveric study
has demonstrated that there is wide variability of injectate
distribution following injection (9). Moreover, steroid
injections tend to cause complications such as nerve insult,
vessel insult, and skin lesions (e.g., color change) (10–12).
Median nerve injury is the most serious complication
associated with local steroid injection for CTS (10).
Therefore, injection under ultrasound (US) guidance may
increase precision and therapeutic outcomes and decrease
complication rates. There are only a few studies that have
investigated US guidance for injections in CTS, and they
generally determined that US-guided injections result
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in better symptom relief and increased and long-lasting
therapeutic effects compared to blind injections (11–13).
Since the studies in this area are limited in number, this
study was conducted to compare the effectiveness of USguided injection versus blind injection of corticosteroids in
the treatment of severe CTS according to symptom severity,
hand function, and electrophysiological parameters.
2. Materials and methods
2.1. Study design
This prospective, randomized clinical trial evaluated
patients who presented to the physical medicine and
rehabilitation outpatient clinic and were treated with a
steroid injection using US-guided versus blind techniques
for severe CTS between March 2016 and January
2017. The diagnosis of CTS was based on clinical and
electrophysiological findings.
The protocol was explained to all patients, and
informed consent was obtained at the beginning of the
study. The ethics committee of the institute approved the
study protocol, and all procedures were performed in
compliance with the Helsinki Declaration (14).
2.2. Participants
Patients with severe idiopathic CTS according to clinical
diagnosis and a validated CTS electrophysiological
severity scale were included in this study. All patients
had complaints of paresthesia and/or numbness along
the median nerve distribution area of the hand with
nocturnal worsening. Patients with systemic diseases such
as inflammatory rheumatic disease, diabetes mellitus,
thyroid disease, history of CTS surgery, or peripheral
nerve lesion of the forearm were excluded from the study.
Demographic data concerning age, sex, dominant hand,
basic symptoms of CTS (pain, weakness, awkwardness),
and duration of symptoms were collected.
The patients were randomly assigned by a computergenerated randomization schedule into two groups as
follows: the blind injection group (n = 19 hands) and the
US-guided injection group (n = 21 hands). The injections
were performed by the same physician (ÖZK).
2.3. Electrophysiological examination
Nerve conduction studies were performed using Medelec
Synergy equipment (Oxford, UK). Bilateral motor and
sensory studies were performed for median and ulnar
nerves according to Oh’s protocol (15). Distal motor
latency, compound muscle action potential (CMAP)
amplitude, sensory nerve conduction velocity (SNCV),
and sensory nerve action potential (SNAP) of the median
nerve were recorded. In line with the prolongation of the
motor and sensory latencies, inability to elicit SNAP or
CMAP with lower amplitude or inability to induce CMAP
were considered signs of severe CTS (15).
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2.4. Injection techniques
In blind injections, after skin antisepsis, a 22-gauge
needle was inserted into the proximal carpal tunnel at the
distal wrist crease found at the ulnar side of the palmaris
longus tendon. The needle was introduced slowly, and
1 mL of betamethasone sodium phosphate (2.63 mg)/
betamethasone dipropionate (6.43 mg) was injected. The
injection was stopped if the patient experienced a “pins
and needles” sensation or pain in the fingers. If resistance
was felt, the needle was withdrawn a few millimeters and
then repositioned.
In US-guided injections, an in-plane approach
was performed. The patient was sitting and the elbow
was flexed 90° with the hand on the cushion/table.
The needle was started from the ulnar aspect of the
transducer while keeping the median nerve in view
(Figure). The US-guided injections were performed
using a 7–12 MHz linear array transducer and a US
device (Logiq P5, GE Medical Systems, USA) (16). All US
examinations were performed by a single physiatrist with
more than 3 years of experience in musculoskeletal US
(ÖZK). The same techniques were used for CTS injection
of the patients with bilateral CTS.

Figure. The position of the transducer and needle during inplane ultrasound-guided approach for carpal tunnel injection.
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2.5. Outcome parameters
The severity of pain was evaluated using a visual analog
scale (17). The Boston questionnaire consists of two
sections: the Boston Symptom Severity Scale (BSSS) and
the Functional Status Scale (FSS) items (18,19). The BSSS
and FSS are the most commonly used outcome measures
of assessment for improvements in clinical symptoms
and functional recovery of patients with CTS. The BSSS
evaluates clinical symptoms, including pain, numbness,
weakness, paresthesia, and clumsiness, using 11 questions
each with 5 separate responses ranging from no complaints
to very severe or continuous complaints. The FSS is
calculated from 8 questions regarding difficulties with
daily activities. Each score is calculated as the mean of the
responses of the individual items. A higher score indicates
the most deteriorated symptom or function.
2.6. Statistical analysis
Statistical analyses were performed using SPSS 13.0 for
Windows (SPSS Inc., Chicago, IL, USA). Normality of
distribution was assessed by Kolmogorov–Smirnov test.
The Fisher exact test was used to assess the qualitative
differences between the groups. Numerical variables were
compared using the Student t-test or Mann–Whitney U test
as appropriate. The paired t-test or Wilcoxon test was used
to reveal whether there was a significant difference within
the groups. When investigating the effect of treatment,
analysis of covariance was used to adjust for differences in
baseline values between the groups. Statistical significance
was set at P < 0.05.
3. Results
A total of 34 patients were enrolled in this study. Three
patients from the blind-injection group were lost to followup and thus a total of 31 CTS patients (N = 40 hands; 9
bilateral, 22 unilateral) completed the study. Demographic
and clinical findings are presented in Table 1. The groups

were similar in terms of findings at baseline, except for
BSSS (P = 0.006) and CMAP (P = 0.009) (Tables 1 and 2).
At follow-up visits performed 4 weeks after the injection,
no complications were encountered.
In both groups, significant differences were
recorded within the groups regarding the clinical and
electrophysiological parameters (Table 2) (all P < 0.05).
Delta (D) analyses are also given in Table 2. Significant
differences were observed between the groups for clinical
parameters (BSSS: P = 0.007; FSS: P < 0.001) in favor of the
US-guided group. Meanwhile, SNAP, SNCV, and CMAP
illustrated more improvements in the blind-injection
group than the US-guided group (P = 0.020, P = 0.008,
and P = 0.044, respectively). After treatment, two patients
had complete improvement only in the US-guided group.
In the US-guided group, a statistically significant decrease
was detected in the cross-sectional area of the median
nerve between pre- and posttreatment values (mean ± SD:
0.18 ± 0.04 and 0.15 ± 0.05, respectively; P = 0.000).
4. Discussion
This study compared the effectiveness of in-plane USguided versus blind injections in the treatment of CTS for
only severe cases. The results indicated that both techniques
were effective in reducing the symptoms, improving
the hand function and all of the electrophysiological
parameters. However, US-guided steroid injection showed
superior results regarding clinical outcomes.
Our findings of improved effectiveness of injections
when they are performed under US guidance are in line
with the results of previous studies (11,12,20). Üstün et
al. compared the efficacy and safety of US-guided versus
blind steroid injections in 46 CTS patients (11). The
authors concluded that although both US-guided and
blind steroid injections were effective in reducing the
symptoms of CTS and improving the function, an earlier

Table 1. Demographics and clinical findings of the patients.
Variables

Blind group
(N = 16)

US-guided group
(N = 15)

P

Age (years)

61.5 ± 10.3

59.4 ± 12.4

0.567

Sex (F/M)

15/1

13/2

0.475

Dominant hand (R/L)

18/1

21/0

0.475

Affected hand (dominant/nondominant)

12/7

10/11

0.252

Involved side (bilateral/unilateral)
Symptom duration (days)

3/13
38.5 ± 40.4

6/9
28.5 ± 3 0.6

0.280
0.381

Pain (VAS, 0–10)

4.0 ± 0.9

4.0 ± 0.8

1.000

Data are given as mean ± SD or ratio.
US, Ultrasound; F, female; M, male; R, right; L, left; VAS, visual analog scale.
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Table 2. Comparison of the clinical variables within and between the groups
Variables

Boston questionnaire
BSSS

FSS

Baseline
After treatment
P
∆ change
ANCOVA*
Baseline
After treatment
P
∆ change

Blind group
(N = 19 hands)

US-guided group
(N = 21 hands)

33.5 ± 5.5
25.5 ± 8.2
<0.001
7.9 ± 6.7

38.6 ± 5.7
21.4 ± 8.9
<0.001
17.1 ± 8.6

0.006
0.138

25.0 ± 6.4
20.0 ± 6.6
0.001
5.0 ± 5.6

28.4 ± 5.7
16.5 ± 7.7
<0.001
12.0 ± 4.7

0.081
0.129

SNAP (µV)

SNCV (m/s)

DML (ms)

CMAP (mV)

0.001
0.007

<0.001
<0.001

ANCOVA*
Electrodiagnostic findings

P

Baseline
After treatment
P
∆ change
ANCOVA*

6.0 ± 7.2
18.1 ± 13.1
0.002
–12.1 ± 14.7

3.9 ± 4.6
8.0 ± 7.2
0.008
–3.9 ± 5.3

Baseline
After treatment
P
∆ change
ANCOVA*

14.0 ± 14.1
27.2 ± 8.0
0.001
–13.3 ± 12.5

10.2 ± 11.7
17.7 ± 13.5
0.010
–6.8 ± 10.8

Baseline
After treatment
P
∆ change
ANCOVA*

6.2 ± 1.2
4.9 ± 1.4
<0.001
1.3 ± 0.9

7.1 ± 1.7
6.3 ± 1.7
<0.001
1.2 ± 0.7

Baseline
After treatment
P
∆ change
ANCOVA*

4.0 ± 1.7
5.8 ± 1.8
0.001
–1.7 ± 1.9

2.4 ± 1.9
3.4 ± 2.4
0.003
–0.9 ± 1.3

0.390
0.004
0.022
0.020
0.294
0.010
0.074
0.008
0.065
0.011
0.169
0.079
0.009
0.001
0.101
0.044

Data are given as mean ± SD. BSSS, Boston Symptom Severity Scale; FSS, Functional Status Scale; SNAP, sensory nerve
action potential; SNCV, sensory nerve conduction velocity; DML, distal motor latency; CMAP, compound muscle
action potential.
*ANCOVA: Analysis of covariance was used to adjust for differences in baseline values between the groups for
investigating the treatment effect.

onset/better improvement of symptoms suggested that
US-guided steroid injection may be more effective than
blind injections in CTS. In another study, which was a
large community-based cohort over a longer period of
follow-up, US-guided injections were found more effective
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in comparison to blind injections in the treatment of
CTS (20). In a study of 44 patients with CTS receiving
corticosteroid injections using either one of two different
US-guided approaches or blind injection, the investigators
reported that US-guided carpal tunnel injections were
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more effective in improving electrodiagnostic and US
findings and symptoms than blind injection, and the
in-plane ulnar approach was superior to the out-plane
approach and blind injections in improving median-toulnar sensory nerve distal latency ratios, CSA, and Boston
questionnaire symptom scores (12). In this study, although
higher improvement rates for SNAP, SNCV, and CMAP
were obtained in the blind-injection group than the USguided group, complete cure was obtained in two patients
only in the US-guided group. CMAP baseline values were
significantly higher in the blind-injection group compared
to the US-guided group. Further improvement in the EMG
parameters in the blind group be can explained by the high
initial CMAP values.
For many years, a wide range of injections have been
performed blindly. After musculoskeletal physicians
started to use US imaging in their clinical practice, they
began to investigate the place of US guidance for injections
(21). In US-guided injection, the structure and location
can be seen and so the physician can view the needle tip
continuously and ensure that the needle is placed precisely
in the desired location, avoiding the risk of damage to
nerves and surrounding structures. Moreover, US enables
visualization of the distribution of the injected substance
with little or no patient discomfort (22,23). The in-plane
method has some advantages, including visualization of
all of the carpal tunnel structures around the nerve, which
facilitates an accurate perineural injection (12). Although
steroid injections are routinely administered for CTS, direct
needle injury of the median nerve is the major complication
of these injections. Racasan et al. reported that the median
nerve is at risk if the injection is performed within 1 cm on
either the ulnar or radial side of the palmaris longus tendon
(10). They reported that the safest location of injection is
through the flexor carpi ulnaris tendon. Patients with CTS
are more vulnerable to needle injury than healthy subjects
even if the needle is inserted at the correct position because
the median nerve is swollen and/or flattened around the
wrist crease. Anatomic variations such as an abnormally

located or bifid median nerve may also affect the procedure
(24). In our study, the bifid median nerve was detected in
one patient, and the injection was performed without any
problem. Complications related to the injection were not
observed in either group.
On the contrary, the most important disadvantage
of US-guided injection is user dependency. US-guided
injection techniques require experience and training. Basic
knowledge of US and detailed knowledge of the anatomy of
the target tissue are required for US-guided interventions.
In the current study, to minimize the user dependency
problem, US examinations and injection procedures were
performed by a single physiatrist with more than 3 years of
experience in musculoskeletal US.
In the present study, marked clinical improvement
occurred in both groups for severe CTS. In the treatment of
severe CTS, steroid injection and surgical decompression
achieved favorable improvements in clinical and
electrophysiological parameters within the short term
without superiority of one treatment over the other (6).
Therefore, in patients for whom surgical decompression
cannot be applied, local steroid injections can be
recommended as a less invasive and a promising treatment
alternative.
A limitation of our study was that the treatment outcome
was assessed only at a 4-week follow-up. As such, we had
no data regarding the long-term benefits/side effects of the
treatments. Additionally, the small sample size may limit
the generalizability of our findings. Nonetheless, we think
that our prospective randomized study contributes to USguided injection studies, particularly in severely affected
cases.
In conclusion, the present study suggests that both USguided and blind steroid injection techniques achieved
favorable improvements, particularly in the symptoms,
hand functions, and electrophysiological findings.
Additionally, US-guided injections may be more effective
regarding clinical findings compared to blind injections in
the treatment of severe CTS cases within the short term.
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